Cargando…

GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function

Degeneration of nigrostriatal dopaminergic system is the principal lesion in Parkinson’s disease. Because glial cell line-derived neurotrophic factor (GDNF) promotes survival of dopamine neurons in vitro and in vivo, intracranial delivery of GDNF has been attempted for Parkinson’s disease treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anmol, Kopra, Jaakko, Varendi, Kärt, Porokuokka, Lauriina L., Panhelainen, Anne, Kuure, Satu, Marshall, Pepin, Karalija, Nina, Härma, Mari-Anne, Vilenius, Carolina, Lilleväli, Kersti, Tekko, Triin, Mijatovic, Jelena, Pulkkinen, Nita, Jakobson, Madis, Jakobson, Maili, Ola, Roxana, Palm, Erik, Lindahl, Maria, Strömberg, Ingrid, Võikar, Vootele, Piepponen, T. Petteri, Saarma, Mart, Andressoo, Jaan-Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682981/
https://www.ncbi.nlm.nih.gov/pubmed/26681446
http://dx.doi.org/10.1371/journal.pgen.1005710
_version_ 1782405954787082240
author Kumar, Anmol
Kopra, Jaakko
Varendi, Kärt
Porokuokka, Lauriina L.
Panhelainen, Anne
Kuure, Satu
Marshall, Pepin
Karalija, Nina
Härma, Mari-Anne
Vilenius, Carolina
Lilleväli, Kersti
Tekko, Triin
Mijatovic, Jelena
Pulkkinen, Nita
Jakobson, Madis
Jakobson, Maili
Ola, Roxana
Palm, Erik
Lindahl, Maria
Strömberg, Ingrid
Võikar, Vootele
Piepponen, T. Petteri
Saarma, Mart
Andressoo, Jaan-Olle
author_facet Kumar, Anmol
Kopra, Jaakko
Varendi, Kärt
Porokuokka, Lauriina L.
Panhelainen, Anne
Kuure, Satu
Marshall, Pepin
Karalija, Nina
Härma, Mari-Anne
Vilenius, Carolina
Lilleväli, Kersti
Tekko, Triin
Mijatovic, Jelena
Pulkkinen, Nita
Jakobson, Madis
Jakobson, Maili
Ola, Roxana
Palm, Erik
Lindahl, Maria
Strömberg, Ingrid
Võikar, Vootele
Piepponen, T. Petteri
Saarma, Mart
Andressoo, Jaan-Olle
author_sort Kumar, Anmol
collection PubMed
description Degeneration of nigrostriatal dopaminergic system is the principal lesion in Parkinson’s disease. Because glial cell line-derived neurotrophic factor (GDNF) promotes survival of dopamine neurons in vitro and in vivo, intracranial delivery of GDNF has been attempted for Parkinson’s disease treatment but with variable success. For improving GDNF-based therapies, knowledge on physiological role of endogenous GDNF at the sites of its expression is important. However, due to limitations of existing genetic model systems, such knowledge is scarce. Here, we report that prevention of transcription of Gdnf 3’UTR in Gdnf endogenous locus yields GDNF hypermorphic mice with increased, but spatially unchanged GDNF expression, enabling analysis of postnatal GDNF function. We found that increased level of GDNF in the central nervous system increases the number of adult dopamine neurons in the substantia nigra pars compacta and the number of dopaminergic terminals in the dorsal striatum. At the functional level, GDNF levels increased striatal tissue dopamine levels and augmented striatal dopamine release and re-uptake. In a proteasome inhibitor lactacystin-induced model of Parkinson’s disease GDNF hypermorphic mice were protected from the reduction in striatal dopamine and failure of dopaminergic system function. Importantly, adverse phenotypic effects associated with spatially unregulated GDNF applications were not observed. Enhanced GDNF levels up-regulated striatal dopamine transporter activity by at least five fold resulting in enhanced susceptibility to 6-OHDA, a toxin transported into dopamine neurons by DAT. Further, we report how GDNF levels regulate kidney development and identify microRNAs miR-9, miR-96, miR-133, and miR-146a as negative regulators of GDNF expression via interaction with Gdnf 3’UTR in vitro. Our results reveal the role of GDNF in nigrostriatal dopamine system postnatal development and adult function, and highlight the importance of correct spatial expression of GDNF. Furthermore, our results suggest that 3’UTR targeting may constitute a useful tool in analyzing gene function.
format Online
Article
Text
id pubmed-4682981
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46829812015-12-31 GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function Kumar, Anmol Kopra, Jaakko Varendi, Kärt Porokuokka, Lauriina L. Panhelainen, Anne Kuure, Satu Marshall, Pepin Karalija, Nina Härma, Mari-Anne Vilenius, Carolina Lilleväli, Kersti Tekko, Triin Mijatovic, Jelena Pulkkinen, Nita Jakobson, Madis Jakobson, Maili Ola, Roxana Palm, Erik Lindahl, Maria Strömberg, Ingrid Võikar, Vootele Piepponen, T. Petteri Saarma, Mart Andressoo, Jaan-Olle PLoS Genet Research Article Degeneration of nigrostriatal dopaminergic system is the principal lesion in Parkinson’s disease. Because glial cell line-derived neurotrophic factor (GDNF) promotes survival of dopamine neurons in vitro and in vivo, intracranial delivery of GDNF has been attempted for Parkinson’s disease treatment but with variable success. For improving GDNF-based therapies, knowledge on physiological role of endogenous GDNF at the sites of its expression is important. However, due to limitations of existing genetic model systems, such knowledge is scarce. Here, we report that prevention of transcription of Gdnf 3’UTR in Gdnf endogenous locus yields GDNF hypermorphic mice with increased, but spatially unchanged GDNF expression, enabling analysis of postnatal GDNF function. We found that increased level of GDNF in the central nervous system increases the number of adult dopamine neurons in the substantia nigra pars compacta and the number of dopaminergic terminals in the dorsal striatum. At the functional level, GDNF levels increased striatal tissue dopamine levels and augmented striatal dopamine release and re-uptake. In a proteasome inhibitor lactacystin-induced model of Parkinson’s disease GDNF hypermorphic mice were protected from the reduction in striatal dopamine and failure of dopaminergic system function. Importantly, adverse phenotypic effects associated with spatially unregulated GDNF applications were not observed. Enhanced GDNF levels up-regulated striatal dopamine transporter activity by at least five fold resulting in enhanced susceptibility to 6-OHDA, a toxin transported into dopamine neurons by DAT. Further, we report how GDNF levels regulate kidney development and identify microRNAs miR-9, miR-96, miR-133, and miR-146a as negative regulators of GDNF expression via interaction with Gdnf 3’UTR in vitro. Our results reveal the role of GDNF in nigrostriatal dopamine system postnatal development and adult function, and highlight the importance of correct spatial expression of GDNF. Furthermore, our results suggest that 3’UTR targeting may constitute a useful tool in analyzing gene function. Public Library of Science 2015-12-17 /pmc/articles/PMC4682981/ /pubmed/26681446 http://dx.doi.org/10.1371/journal.pgen.1005710 Text en © 2015 Kumar et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kumar, Anmol
Kopra, Jaakko
Varendi, Kärt
Porokuokka, Lauriina L.
Panhelainen, Anne
Kuure, Satu
Marshall, Pepin
Karalija, Nina
Härma, Mari-Anne
Vilenius, Carolina
Lilleväli, Kersti
Tekko, Triin
Mijatovic, Jelena
Pulkkinen, Nita
Jakobson, Madis
Jakobson, Maili
Ola, Roxana
Palm, Erik
Lindahl, Maria
Strömberg, Ingrid
Võikar, Vootele
Piepponen, T. Petteri
Saarma, Mart
Andressoo, Jaan-Olle
GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title_full GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title_fullStr GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title_full_unstemmed GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title_short GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
title_sort gdnf overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682981/
https://www.ncbi.nlm.nih.gov/pubmed/26681446
http://dx.doi.org/10.1371/journal.pgen.1005710
work_keys_str_mv AT kumaranmol gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT koprajaakko gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT varendikart gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT porokuokkalauriinal gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT panhelainenanne gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT kuuresatu gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT marshallpepin gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT karalijanina gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT harmamarianne gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT vileniuscarolina gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT lillevalikersti gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT tekkotriin gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT mijatovicjelena gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT pulkkinennita gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT jakobsonmadis gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT jakobsonmaili gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT olaroxana gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT palmerik gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT lindahlmaria gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT strombergingrid gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT voikarvootele gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT piepponentpetteri gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT saarmamart gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction
AT andressoojaanolle gdnfoverexpressionfromthenativelocusrevealsitsroleinthenigrostriataldopaminergicsystemfunction